Quarterly ResultApr 21, 2026, 06:52 AM
Quest Diagnostics Q1 Revenue Up 9.2% to $2.9B; Raises FY26 EPS Guidance
AI Summary
Quest Diagnostics reported strong first-quarter 2026 financial results, with revenues increasing 9.2% to $2.90 billion, driven by 9.0% organic growth. Reported diluted EPS rose 15.5% to $2.24, and adjusted diluted EPS increased 13.1% to $2.50. Following these results, the company raised its full-year 2026 reported and adjusted diluted EPS guidance, reflecting disciplined execution and a positive outlook.
Key Highlights
- Q1 2026 revenue: $2.90 billion, up 9.2% year-over-year.
- Q1 2026 organic revenue growth: 9.0%.
- Q1 2026 reported diluted EPS: $2.24, up 15.5%.
- Q1 2026 adjusted diluted EPS: $2.50, up 13.1%.
- FY26 adjusted diluted EPS guidance raised to $10.63-$10.83.